Oral Rabies Vaccine Trial; Availability of a Supplemental Environmental Assessment, 32676-32677 [2017-14921]
Download as PDF
32676
Notices
Federal Register
Vol. 82, No. 135
Monday, July 17, 2017
This section of the FEDERAL REGISTER
contains documents other than rules or
proposed rules that are applicable to the
public. Notices of hearings and investigations,
committee meetings, agency decisions and
rulings, delegations of authority, filing of
petitions and applications and agency
statements of organization and functions are
examples of documents appearing in this
section.
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2017–0046]
Oral Rabies Vaccine Trial; Availability
of a Supplemental Environmental
Assessment
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of availability and
request for comments.
AGENCY:
We are advising the public
that the Animal and Plant Health
Inspection Service has prepared a
supplemental environmental assessment
(EA) relative to an oral rabies
vaccination field trial in New
Hampshire, New York, Ohio, Vermont,
and West Virginia. The supplemental
EA analyzes expanding the field trial for
an experimental oral rabies vaccine for
wildlife to additional areas in New
York, Ohio, and West Virginia. The
proposed field trial is necessary to
evaluate whether the wildlife rabies
vaccine will produce sufficient levels of
population immunity against raccoon
rabies. We are making the supplemental
EA available to the public for review
and comment.
DATES: We will consider all comments
that we receive on or before August 16,
2017.
ADDRESSES: You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/
#!docketDetail;D=APHIS-2017-0046.
• Postal Mail/Commercial Delivery:
Send your comment to Docket No.
APHIS–2017–0046, Regulatory Analysis
and Development, PPD, APHIS, Station
3A–03.8, 4700 River Road, Unit 118,
Riverdale, MD 20737–1238.
The supplemental environmental
assessment and any comments we
receive may be viewed at https://
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:45 Jul 14, 2017
Jkt 241001
www.regulations.gov/
#!docketDetail;D=APHIS-2017-0046 or
in our reading room, which is located in
room 1141 of the USDA South Building,
14th Street and Independence Avenue
SW., Washington, DC. Normal reading
room hours are 8 a.m. to 4:30 p.m.,
Monday through Friday, except
holidays. To be sure someone is there to
help you, please call (202) 799–7039
before coming.
This notice and the supplemental EA
are also posted on the APHIS Web site
at https://www.aphis.usda.gov/
regulations/ws/ws_nepa_
environmental_documents.shtml.
FOR FURTHER INFORMATION CONTACT: Mr.
Richard Chipman, Rabies Program
Coordinator, Wildlife Services, APHIS,
59 Chennell Drive, Suite 7, Concord, NH
03301; (603) 223–9623, email:
richard.b.chipman@aphis.usda.gov. To
obtain copies of the supplemental
environmental assessment, contact Ms.
Beth Kabert, Staff Wildlife Biologist,
Wildlife Services, 140–C Locust Grove
Road, Pittstown, NJ 08867; (908) 735–
5654, fax (908) 735–0821, email:
beth.e.kabert@aphis.usda.gov.
SUPPLEMENTARY INFORMATION: The
Wildlife Services (WS) program in the
Animal and Plant Health Inspection
Service (APHIS) cooperates with
Federal agencies, State and local
governments, and private individuals to
research and implement the best
methods of managing conflicts between
wildlife and human health and safety,
agriculture, property, and natural
resources. Wildlife-borne diseases that
can affect domestic animals and humans
are among the types of conflicts that
APHIS–WS addresses. Wildlife is the
dominant reservoir of rabies in the
United States.
Currently, APHIS–WS conducts an
oral rabies vaccination (ORV) program
to control the spread of rabies. The ORV
program has utilized a vaccinia-rabies
glycoprotein (V–RG) vaccine. APHIS–
WS’ use of the V–RG vaccine has
resulted in several notable
accomplishments, including the
elimination of canine rabies from
sources in Mexico, the successful
control of gray fox rabies virus variant
in western Texas, and the prevention of
any appreciable spread of raccoon rabies
in the eastern United States. While the
prevention of any appreciable spread of
raccoon rabies in the eastern United
States represents a major
PO 00000
Frm 00001
Fmt 4703
Sfmt 4703
accomplishment in rabies management,
the V–RG vaccine has not been effective
in eliminating raccoon rabies from highrisk spread corridors. This fact
prompted APHIS–WS to evaluate rabies
vaccines capable of producing higher
levels of population immunity against
raccoon rabies to better control the
spread of this disease.
In 2011, APHIS–WS initiated a field
trial to study the immunogenicity and
safety of a promising new wildlife rabies
vaccine, human adenovirus type 5
rabies glycoprotein recombinant vaccine
in portions of West Virginia, including
U.S. Department of Agriculture Forest
Service National Forest System lands.
The vaccine used in this field trial is an
experimental oral rabies vaccine called
ONRAB (produced by Artemis
Technologies Inc., Guelph, Ontario,
Canada).
To further assess the immunogenicity
of ONRAB in raccoons and skunks for
raccoon rabies virus variant, APHIS–WS
determined the need to expand the field
trial into portions of New Hampshire,
New York, Ohio, Vermont, and West
Virginia, including National Forest
System lands. On July 9, 2012, we
published in the Federal Register (77
FR 40322–40323, Docket No. APHIS–
2012–0052) a notice 1 in which we
announced the availability, for public
review and comment, of an
environmental assessment (EA) that
examined the potential environmental
impacts associated with the proposed
field trial to test the safety and efficacy
of the ONRAB vaccine in New
Hampshire, New York, Ohio, Vermont,
and West Virginia. We announced the
availability of our final EA and finding
of no significant impact (FONSI) in a
notice published in the Federal Register
(see footnote 1) on August 16, 2012 (77
FR 49409–49410, Docket No. APHIS–
2012–0052).
On July 17, 2015, we published in the
Federal Register (80 FR 42467–42469,
Docket No. APHIS–2015–0047) a
notice 2 in which we announced the
availability, for public review and
comment, of a supplemental EA that
examined the potential environmental
impacts associated with expanding the
1 To view the notice, the comments we received,
the EA, and the follow-up finding of no significant
impact, go to https://www.regulations.gov/
#!docketDetail;D=APHIS-2012-0052.
2 To view the notice, the supplemental EA, and
the FONSI, go to https://www.regulations.gov/
#!docketDetail;D= APHIS-2015-0047.
E:\FR\FM\17JYN1.SGM
17JYN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
field trial to additional areas in Ohio
and increasing bait distribution density
in portions of West Virginia. We
announced the availability of our final
EA and FONSI in a notice published in
the Federal Register (see footnote 2) on
September 17, 2015 (80 FR 55826–
55827, Docket No. APHIS–2015–0047).
In 2017, there were two confirmed
cases of raccoon variant rabies 8–10 km
(5–6 miles) west of the established V–
RG ORV zone in Ohio (approximately
20 km [12 miles]) east of the city of
Canton, OH). To address this
emergency, APHIS–WS proposes to shift
the existing ORV zone in Ohio in an
effort to contain the outbreak and to
secure the zone. ONRAB vaccine-baits
will be distributed in this revised
portion of the ORV zone.
APHIS–WS is also proposing to add
Webster, Braxton, Nicholas, Wyoming,
McDowell, Upshur, Barbour, Harrison,
Lewis, Tyler, Ritchie, Doddridge,
Wetzel, Taylor, Marion, Monongalia,
and Preston Counties in West Virginia
so that ONRAB vaccine-baits may be
applied to the western edge of the ORV
zone in West Virginia to provide added
confidence in the seroconversion rates
based on results from previous field
trials. This will provide an opportunity
to improve serological sampling
spatially throughout the zone as part of
an increased monitoring initiative.
Finally, APHIS–WS is proposing to
expand the field trial zone in New York
into Oswego County. The current ORV
ONRAB zone in New York includes
Jefferson County, which shares a border
with Oswego County. Current ONRAB
bait distribution occurs very close to the
Oswego County border and including
this county will allow APHIS–WS to
opportunistically distribute any
remaining excess baits while collecting
additional serological data to further
assess the field trial.
APHIS–WS has prepared a
supplemental EA in which we analyze
expanding the area of the field trial zone
in New York, Ohio, and West Virginia.
We are making the supplemental EA
available to the public for review and
comment. We will consider all
comments that we receive on or before
the date listed under the heading DATES
at the beginning of this notice.
The supplemental EA may be viewed
on the Regulations.gov Web site or in
our reading room (see ADDRESSES above
for instructions for accessing
Regulations.gov and information on the
location and hours of the reading room).
In addition, paper copies may be
obtained by calling or writing to the
individual listed under FOR FURTHER
INFORMATION CONTACT.
VerDate Sep<11>2014
18:21 Jul 14, 2017
Jkt 241001
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provisions
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
Done in Washington, DC, this 12th day of
July 2017.
Michael C. Gregoire,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 2017–14921 Filed 7–14–17; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF AGRICULTURE
Grain Inspection, Packers and
Stockyards Administration
United States Standards for Lentils
Correction
In notice document 2017–14803,
appearing on pages 31550–31551 in the
Issue of Friday, July 7, 2017, make the
following correction:
On page 31551, in the table titled
‘‘607 GRADES AND GRADE
REQUIREMENTS FOR DOCKAGE-FREE
LENTILS’’, in the tenth row, in the
fourth column, the entry ‘‘<4.0’’ should
read ‘‘>4.0’’.
[FR Doc. C1–2017–14308 Filed 7–14–17; 8:45 am]
BILLING CODE 1301–00–D
DEPARTMENT OF COMMERCE
U.S. Census Bureau
Proposed Information Collection;
Comment Request; Annual Wholesale
Trade Survey
U.S. Census Bureau,
Commerce.
ACTION: Notice.
AGENCY:
The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden, invites the general
public and other Federal agencies to
take this opportunity to comment on
proposed and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995.
DATES: To ensure consideration, written
comments must be submitted on or
before September 15, 2017.
ADDRESSES: Direct all written comments
to Jennifer Jessup, Departmental
SUMMARY:
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
32677
Paperwork Clearance Officer,
Department of Commerce, Room 6616,
14th and Constitution Avenue NW.,
Washington, DC 20230 (or via the
Internet at PRAcomments@doc.gov).
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
instrument(s) and instructions should
be directed to Susan Pozzanghera,
Economy-Wide Statistics Division, U.S.
Census Bureau, (301) 763–7169 or via
email at ewd.annual.wholesale
.trade.survey@census.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The Annual Wholesale Trade Survey
(AWTS) covers employer firms with
establishments located in the United
States and classified in wholesale trade
sector as defined by the North American
Industry Classification System (NAICS).
This sector include distributors,
manufacturers’ sales branches and
offices, as well as agents and brokers.
Firms are selected for this survey
using a stratified random sample where
strata are defined by type of operation,
industry, and annual sales size. The
sample is drawn from the Business
Register (BR), which is the Census
Bureau’s master business list containing
basic economic information for over 7.4
million employer businesses and over
22.5 million nonemployer businesses.
The BR obtains information using
direct data collections and
administrative record information from
federal agencies. The AWTS sample is
updated quarterly to reflect business
‘‘births’’ and ‘‘deaths’’ by adding newly
established employer businesses and
deleting companies when it is
determined they are no longer active.
The AWTS introduced a new sample
for 2016. The Census Bureau requested
two years of data from all sample firms
in order to link the old and new
samples, ensuring that the published
estimates continue to be reliable and
accurate. The 2017 AWTS and
subsequent years will request one year
of data until a new sample is selected
again in five years. The 2017 AWTS will
also collect detailed business
expenditure items and sales tax data, in
response to a request for this data from
the Bureau of Economic Analysis (BEA).
These data items are collected on the
AWTS survey in years ending in 2 and
7, which coincide with the economic
census collection.
The AWTS data is collected
electronically using the Census Bureau’s
secure online reporting instrument
(Centurion). This electronic system of
reporting is designed to allow
E:\FR\FM\17JYN1.SGM
17JYN1
Agencies
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Notices]
[Pages 32676-32677]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14921]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 /
Notices
[[Page 32676]]
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. APHIS-2017-0046]
Oral Rabies Vaccine Trial; Availability of a Supplemental
Environmental Assessment
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice of availability and request for comments.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared a supplemental environmental assessment
(EA) relative to an oral rabies vaccination field trial in New
Hampshire, New York, Ohio, Vermont, and West Virginia. The supplemental
EA analyzes expanding the field trial for an experimental oral rabies
vaccine for wildlife to additional areas in New York, Ohio, and West
Virginia. The proposed field trial is necessary to evaluate whether the
wildlife rabies vaccine will produce sufficient levels of population
immunity against raccoon rabies. We are making the supplemental EA
available to the public for review and comment.
DATES: We will consider all comments that we receive on or before
August 16, 2017.
ADDRESSES: You may submit comments by either of the following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov/#!docketDetail;D=APHIS-2017-0046.
Postal Mail/Commercial Delivery: Send your comment to
Docket No. APHIS-2017-0046, Regulatory Analysis and Development, PPD,
APHIS, Station 3A-03.8, 4700 River Road, Unit 118, Riverdale, MD 20737-
1238.
The supplemental environmental assessment and any comments we
receive may be viewed at https://www.regulations.gov/#!docketDetail;D=APHIS-2017-0046 or in our reading room, which is
located in room 1141 of the USDA South Building, 14th Street and
Independence Avenue SW., Washington, DC. Normal reading room hours are
8 a.m. to 4:30 p.m., Monday through Friday, except holidays. To be sure
someone is there to help you, please call (202) 799-7039 before coming.
This notice and the supplemental EA are also posted on the APHIS
Web site at https://www.aphis.usda.gov/regulations/ws/ws_nepa_environmental_documents.shtml.
FOR FURTHER INFORMATION CONTACT: Mr. Richard Chipman, Rabies Program
Coordinator, Wildlife Services, APHIS, 59 Chennell Drive, Suite 7,
Concord, NH 03301; (603) 223-9623, email:
richard.b.chipman@aphis.usda.gov. To obtain copies of the supplemental
environmental assessment, contact Ms. Beth Kabert, Staff Wildlife
Biologist, Wildlife Services, 140-C Locust Grove Road, Pittstown, NJ
08867; (908) 735-5654, fax (908) 735-0821, email:
beth.e.kabert@aphis.usda.gov.
SUPPLEMENTARY INFORMATION: The Wildlife Services (WS) program in the
Animal and Plant Health Inspection Service (APHIS) cooperates with
Federal agencies, State and local governments, and private individuals
to research and implement the best methods of managing conflicts
between wildlife and human health and safety, agriculture, property,
and natural resources. Wildlife-borne diseases that can affect domestic
animals and humans are among the types of conflicts that APHIS-WS
addresses. Wildlife is the dominant reservoir of rabies in the United
States.
Currently, APHIS-WS conducts an oral rabies vaccination (ORV)
program to control the spread of rabies. The ORV program has utilized a
vaccinia-rabies glycoprotein (V-RG) vaccine. APHIS-WS' use of the V-RG
vaccine has resulted in several notable accomplishments, including the
elimination of canine rabies from sources in Mexico, the successful
control of gray fox rabies virus variant in western Texas, and the
prevention of any appreciable spread of raccoon rabies in the eastern
United States. While the prevention of any appreciable spread of
raccoon rabies in the eastern United States represents a major
accomplishment in rabies management, the V-RG vaccine has not been
effective in eliminating raccoon rabies from high-risk spread
corridors. This fact prompted APHIS-WS to evaluate rabies vaccines
capable of producing higher levels of population immunity against
raccoon rabies to better control the spread of this disease.
In 2011, APHIS-WS initiated a field trial to study the
immunogenicity and safety of a promising new wildlife rabies vaccine,
human adenovirus type 5 rabies glycoprotein recombinant vaccine in
portions of West Virginia, including U.S. Department of Agriculture
Forest Service National Forest System lands. The vaccine used in this
field trial is an experimental oral rabies vaccine called ONRAB
(produced by Artemis Technologies Inc., Guelph, Ontario, Canada).
To further assess the immunogenicity of ONRAB in raccoons and
skunks for raccoon rabies virus variant, APHIS-WS determined the need
to expand the field trial into portions of New Hampshire, New York,
Ohio, Vermont, and West Virginia, including National Forest System
lands. On July 9, 2012, we published in the Federal Register (77 FR
40322-40323, Docket No. APHIS-2012-0052) a notice \1\ in which we
announced the availability, for public review and comment, of an
environmental assessment (EA) that examined the potential environmental
impacts associated with the proposed field trial to test the safety and
efficacy of the ONRAB vaccine in New Hampshire, New York, Ohio,
Vermont, and West Virginia. We announced the availability of our final
EA and finding of no significant impact (FONSI) in a notice published
in the Federal Register (see footnote 1) on August 16, 2012 (77 FR
49409-49410, Docket No. APHIS-2012-0052).
---------------------------------------------------------------------------
\1\ To view the notice, the comments we received, the EA, and
the follow-up finding of no significant impact, go to https://www.regulations.gov/#!docketDetail;D=APHIS-2012-0052.
---------------------------------------------------------------------------
On July 17, 2015, we published in the Federal Register (80 FR
42467-42469, Docket No. APHIS-2015-0047) a notice \2\ in which we
announced the availability, for public review and comment, of a
supplemental EA that examined the potential environmental impacts
associated with expanding the
[[Page 32677]]
field trial to additional areas in Ohio and increasing bait
distribution density in portions of West Virginia. We announced the
availability of our final EA and FONSI in a notice published in the
Federal Register (see footnote 2) on September 17, 2015 (80 FR 55826-
55827, Docket No. APHIS-2015-0047).
---------------------------------------------------------------------------
\2\ To view the notice, the supplemental EA, and the FONSI, go
to https://www.regulations.gov/#!docketDetail;D= APHIS-2015-0047.
---------------------------------------------------------------------------
In 2017, there were two confirmed cases of raccoon variant rabies
8-10 km (5-6 miles) west of the established V-RG ORV zone in Ohio
(approximately 20 km [12 miles]) east of the city of Canton, OH). To
address this emergency, APHIS-WS proposes to shift the existing ORV
zone in Ohio in an effort to contain the outbreak and to secure the
zone. ONRAB vaccine-baits will be distributed in this revised portion
of the ORV zone.
APHIS-WS is also proposing to add Webster, Braxton, Nicholas,
Wyoming, McDowell, Upshur, Barbour, Harrison, Lewis, Tyler, Ritchie,
Doddridge, Wetzel, Taylor, Marion, Monongalia, and Preston Counties in
West Virginia so that ONRAB vaccine-baits may be applied to the western
edge of the ORV zone in West Virginia to provide added confidence in
the seroconversion rates based on results from previous field trials.
This will provide an opportunity to improve serological sampling
spatially throughout the zone as part of an increased monitoring
initiative.
Finally, APHIS-WS is proposing to expand the field trial zone in
New York into Oswego County. The current ORV ONRAB zone in New York
includes Jefferson County, which shares a border with Oswego County.
Current ONRAB bait distribution occurs very close to the Oswego County
border and including this county will allow APHIS-WS to
opportunistically distribute any remaining excess baits while
collecting additional serological data to further assess the field
trial.
APHIS-WS has prepared a supplemental EA in which we analyze
expanding the area of the field trial zone in New York, Ohio, and West
Virginia. We are making the supplemental EA available to the public for
review and comment. We will consider all comments that we receive on or
before the date listed under the heading DATES at the beginning of this
notice.
The supplemental EA may be viewed on the Regulations.gov Web site
or in our reading room (see ADDRESSES above for instructions for
accessing Regulations.gov and information on the location and hours of
the reading room). In addition, paper copies may be obtained by calling
or writing to the individual listed under FOR FURTHER INFORMATION
CONTACT.
The EA has been prepared in accordance with: (1) The National
Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on Environmental Quality for
implementing the procedural provisions of NEPA (40 CFR parts 1500-
1508), (3) USDA regulations implementing NEPA (7 CFR part 1b), and (4)
APHIS' NEPA Implementing Procedures (7 CFR part 372).
Done in Washington, DC, this 12th day of July 2017.
Michael C. Gregoire,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 2017-14921 Filed 7-14-17; 8:45 am]
BILLING CODE 3410-34-P